669 related articles for article (PubMed ID: 15695783)
1. The value of 99mTc-sestamibi SPECT/CT over conventional SPECT in the evaluation of parathyroid adenomas or hyperplasia.
Gayed IW; Kim EE; Broussard WF; Evans D; Lee J; Broemeling LD; Ochoa BB; Moxley DM; Erwin WD; Podoloff DA
J Nucl Med; 2005 Feb; 46(2):248-52. PubMed ID: 15695783
[TBL] [Abstract][Full Text] [Related]
2. Parathyroid 99mTc-sestamibi scintigraphy: dual-tracer subtraction is superior to double-phase washout.
Leslie WD; Dupont JO; Bybel B; Riese KT
Eur J Nucl Med Mol Imaging; 2002 Dec; 29(12):1566-70. PubMed ID: 12458389
[TBL] [Abstract][Full Text] [Related]
3. Technetium 99m tetrofosmin parathyroid imaging. Results with double-phase study and SPECT in primary and secondary hyperparathyroidism.
Gallowitsch HJ; Mikosch P; Kresnik E; Gomez I; Lind P
Invest Radiol; 1997 Aug; 32(8):459-65. PubMed ID: 9258734
[TBL] [Abstract][Full Text] [Related]
4. Comparison of SPECT/CT, SPECT, and planar imaging with single- and dual-phase (99m)Tc-sestamibi parathyroid scintigraphy.
Lavely WC; Goetze S; Friedman KP; Leal JP; Zhang Z; Garret-Mayer E; Dackiw AP; Tufano RP; Zeiger MA; Ziessman HA
J Nucl Med; 2007 Jul; 48(7):1084-9. PubMed ID: 17574983
[TBL] [Abstract][Full Text] [Related]
5. Clinical utility of ultrasound and 99mTc sestamibi SPECT/CT for preoperative localization of parathyroid adenoma in patients with primary hyperparathyroidism.
Patel CN; Salahudeen HM; Lansdown M; Scarsbrook AF
Clin Radiol; 2010 Apr; 65(4):278-87. PubMed ID: 20338394
[TBL] [Abstract][Full Text] [Related]
6. Comparison of parathyroid imaging with technetium-99m-pertechnetate/sestamibi subtraction, double-phase technetium-99m-sestamibi and technetium-99m-sestamibi SPECT.
Chen CC; Holder LE; Scovill WA; Tehan AM; Gann DS
J Nucl Med; 1997 Jun; 38(6):834-9. PubMed ID: 9189125
[TBL] [Abstract][Full Text] [Related]
7. The usefulness of neck pinhole SPECT as a complementary tool to planar scintigraphy in primary and secondary hyperparathyroidism.
Spanu A; Falchi A; Manca A; Marongiu P; Cossu A; Pisu N; Chessa F; Nuvoli S; Madeddu G
J Nucl Med; 2004 Jan; 45(1):40-8. PubMed ID: 14734671
[TBL] [Abstract][Full Text] [Related]
8. Technetium-99m-MIBI SPECT/CT in primary hyperparathyroidism.
Krausz Y; Bettman L; Guralnik L; Yosilevsky G; Keidar Z; Bar-Shalom R; Even-Sapir E; Chisin R; Israel O
World J Surg; 2006 Jan; 30(1):76-83. PubMed ID: 16369710
[TBL] [Abstract][Full Text] [Related]
9. Preoperative 123I/99mTc-sestamibi subtraction SPECT and SPECT/CT in primary hyperparathyroidism.
Neumann DR; Obuchowski NA; Difilippo FP
J Nucl Med; 2008 Dec; 49(12):2012-7. PubMed ID: 18997051
[TBL] [Abstract][Full Text] [Related]
10. Dual-phase 99mTc-sestamibi imaging: its utility in parathyroid hyperplasia and use of immediate/delayed image ratios to improve diagnosis of hyperparathyroidism.
Gordon L; Burkhalter W; Mah E
J Nucl Med Technol; 2002 Dec; 30(4):179-84. PubMed ID: 12446751
[TBL] [Abstract][Full Text] [Related]
11. Role of SPECT/CT in the preoperative assessment of hyperparathyroid patients.
Serra A; Bolasco P; Satta L; Nicolosi A; Uccheddu A; Piga M
Radiol Med; 2006 Oct; 111(7):999-1008. PubMed ID: 17021682
[TBL] [Abstract][Full Text] [Related]
12. Incremental diagnostic value of preoperative 99mTc-MIBI SPECT in patients with a parathyroid adenoma.
Lorberboym M; Minski I; Macadziob S; Nikolov G; Schachter P
J Nucl Med; 2003 Jun; 44(6):904-8. PubMed ID: 12791817
[TBL] [Abstract][Full Text] [Related]
13. Preoperative ⁹⁹mTc-sestamibi scintigraphy in patients with primary hyperparathyroidism and concomitant nodular goiter: comparison of SPECT-CT, SPECT, and planar imaging.
Shafiei B; Hoseinzadeh S; Fotouhi F; Malek H; Azizi F; Jahed A; Hadaegh F; Salehian M; Parsa H; Javadi H; Assadi M
Nucl Med Commun; 2012 Oct; 33(10):1070-6. PubMed ID: 22825041
[TBL] [Abstract][Full Text] [Related]
14. The Usefulness of Maximum Standardized Uptake Value at the Delayed Phase of Tc-99m sestamibi single-photon emission computed tomography/computed tomography for Identification of Parathyroid Adenoma and Hyperplasia.
Suh HY; Na HY; Park SY; Choi JY; So Y; Lee WW;
Medicine (Baltimore); 2020 Jul; 99(28):e21176. PubMed ID: 32664158
[TBL] [Abstract][Full Text] [Related]
15. Parathyroid adenomas: accurate detection and localization with Tc-99m sestamibi SPECT.
Perez-Monte JE; Brown ML; Shah AN; Ranger NT; Watson CG; Carty SE; Clarke MR
Radiology; 1996 Oct; 201(1):85-91. PubMed ID: 8816526
[TBL] [Abstract][Full Text] [Related]
16. Comparison of double-phase 99mTc-sestamibi with 123I-99mTc-sestamibi subtraction SPECT in hyperparathyroidism.
Neumann DR; Esselstyn CB; Go RT; Wong CO; Rice TW; Obuchowski NA
AJR Am J Roentgenol; 1997 Dec; 169(6):1671-4. PubMed ID: 9393188
[TBL] [Abstract][Full Text] [Related]
17. Early, postinjection MIBI-SPECT as the only preoperative localizing study for minimally invasive parathyroidectomy.
Schachter PP; Issa N; Shimonov M; Czerniak A; Lorberboym M
Arch Surg; 2004 Apr; 139(4):433-7. PubMed ID: 15078713
[TBL] [Abstract][Full Text] [Related]
18. Comparison between 99mTc-tetrofosmin/pertechnetate subtraction scintigraphy and 99mTc-tetrofosmin SPECT for preoperative localization of parathyroid adenoma in an endemic goiter area.
Gallowitsch HJ; Mikosch P; Kresnik E; Unterweger O; Lind P
Invest Radiol; 2000 Aug; 35(8):453-9. PubMed ID: 10946972
[TBL] [Abstract][Full Text] [Related]
19. A comparison between 11C-methionine PET/CT and MIBI SPECT/CT for localization of parathyroid adenomas/hyperplasia.
Hayakawa N; Nakamoto Y; Kurihara K; Yasoda A; Kanamoto N; Miura M; Inagaki N; Togashi K
Nucl Med Commun; 2015 Jan; 36(1):53-9. PubMed ID: 25244350
[TBL] [Abstract][Full Text] [Related]
20. Parathyroid imaging and localization using SPECT/CT: initial results.
Vaz A; Griffiths M
J Nucl Med Technol; 2011 Sep; 39(3):195-200. PubMed ID: 21795371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
